Log | Progress In Mind

Log Type	Authored on	Log Message	Authored by
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/boom-ou-%C3%A9chec-des-biomarqueurs-l%E2%80%99h%C3%A9t%C3%A9rog%C3%A9n%C3%A9it%C3%A9-de-la-maladie-de-parkinson-freine-t-elle	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3336	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/boom-ou-%C3%A9chec-des-biomarqueurs-l%E2%80%99h%C3%A9t%C3%A9rog%C3%A9n%C3%A9it%C3%A9-de-la-maladie-de-parkinson-freine-t-elle	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3336	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/boom-ou-%C3%A9chec-des-biomarqueurs-l%E2%80%99h%C3%A9t%C3%A9rog%C3%A9n%C3%A9it%C3%A9-de-la-maladie-de-parkinson-freine-t-elle	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3327	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3337	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/%C3%A0-quel-point-l%E2%80%99inhibition-de-la-cholinest%C3%A9rase-est-elle-b%C3%A9n%C3%A9fique-et-chez-quels-patients	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3327	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/schizophr%C3%A9nie-%E2%80%93-des-prodromes-%C3%A0-la-psychose	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3327	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3340	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3340	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/soins-collaboratifs-pour-la-d%C3%A9pression-comorbide-rapport-co%C3%BBt-efficacit%C3%A9-et-mise-en-%C5%93uvre	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://progress.im/fr/newsletter/confirm/remove/*	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst

Log Type	Authored on	Log Message	Authored by
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/boom-ou-%C3%A9chec-des-biomarqueurs-l%E2%80%99h%C3%A9t%C3%A9rog%C3%A9n%C3%A9it%C3%A9-de-la-maladie-de-parkinson-freine-t-elle	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3336	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/boom-ou-%C3%A9chec-des-biomarqueurs-l%E2%80%99h%C3%A9t%C3%A9rog%C3%A9n%C3%A9it%C3%A9-de-la-maladie-de-parkinson-freine-t-elle	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3336	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/boom-ou-%C3%A9chec-des-biomarqueurs-l%E2%80%99h%C3%A9t%C3%A9rog%C3%A9n%C3%A9it%C3%A9-de-la-maladie-de-parkinson-freine-t-elle	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3327	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3337	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/%C3%A0-quel-point-l%E2%80%99inhibition-de-la-cholinest%C3%A9rase-est-elle-b%C3%A9n%C3%A9fique-et-chez-quels-patients	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3327	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/schizophr%C3%A9nie-%E2%80%93-des-prodromes-%C3%A0-la-psychose	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3327	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3340	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/fr/node/3340	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://france.progress.im/en/content/soins-collaboratifs-pour-la-d%C3%A9pression-comorbide-rapport-co%C3%BBt-efficacit%C3%A9-et-mise-en-%C5%93uvre	Gäst
Newsletter clicked	Thu, 10/13/2022 - 11:15	Clicked https://progress.im/fr/newsletter/confirm/remove/*	Gäst
Newsletter opened	Wed, 10/12/2022 - 07:28	Opened	Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER